# CARE1 (NCT06364631)

> CARE1 Pragmatic Clinical Trial

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT06364631
- Phase: PHASE3
- Status: RECRUITING
- Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
- Conditions: Metastatic Kidney Cancer; Metastatic Kidney Carcinoma
- Interventions: Nivolumab; Ipilimumab; Pembrolizumab; Cabozantinib; Axitinib; Lenvatinib
- Enrollment: 1250
- Primary outcome: Overall Survival (OS).

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- X threads: 24
- YouTube: 9
- Podcasts: 5
- Bluesky threads: 1
- X videos: 1

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=care1-nct06364631

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT06364631", "email": "<work email>"}; the inbox owner confirms by the emailed link.